Article
Genetic imaging consortium for addiction medicine: From neuroimaging to genes.
Progress in brain research - 1 Jan 2016
Mackey Scott, Kan Kees-Jan, Chaarani Bader, Alia-Klein Nelly, Batalla Albert, Brooks Samantha, Cousijn Janna, Dagher Alain, de Ruiter Michiel, Desrivieres Sylvane, Feldstein Ewing Sarah W, Goldstein Rita Z, Goudriaan Anna E, Heitzeg Mary M, Hutchison Kent, Li Chiang-Shan R, London Edythe D, Lorenzetti Valentina, Luijten Maartje, Martin-Santos Rocio, Morales Angelica M, Paulus Martin P, Paus Tomas, Pearlson Godfrey, Schluter Renée, Momenan Reza, Schmaal Lianne, Schumann Gunter, Sinha Rajita, Sjoerds Zsuzsika, Stein Dan J, Stein Elliot A, Solowij Nadia, Tapert Susan, Uhlmann Anne, Veltman Dick, van Holst Ruth, Walter Henrik, Wright Margaret J, Yucel Murat, Yurgelun-Todd Deborah, Hibar Derrek P, Jahanshad Neda, Thompson Paul M, Glahn David C, Garavan Hugh, Conrod Patricia
Abstract excerpt
Since the sample size of a typical neuroimaging study lacks sufficient statistical power to explore unknown genomic associations with brain phenotypes, several international genetic imaging consortia have been organized in recent years to pool data across sites. The challenges and achievements of these consortia are considered here with the goal of leveraging these resources to study addiction. The authors of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
